Literature DB >> 11682161

Naloxone fails to produce conditioned place aversion in mu-opioid receptor knock-out mice.

P D Skoubis1, H W Matthes, W M Walwyn, B L Kieffer, N T Maidment.   

Abstract

There is growing evidence that tonic activity of the opioid system may be important in the modulation of affective state. Naloxone produces a conditioned place aversion in rodents, an effect that is centrally mediated. Previous pharmacological data using antagonists with preferential actions at mu-, delta-, and kappa-opioid receptors indicate the importance of the mu-opioid receptor in mediating this effect. We sought to test the mu-opioid receptor selectivity of naloxone aversion using mu-opioid receptor knock-out mice. mu-Opioid receptor knock-out and wild-type mice were tested for naloxone (10 mg/kg, s.c.) aversion using a place conditioning paradigm. As a positive control for associative learning, knock-out mice were tested for conditioned place aversion to a kappa agonist, U50,488H (2 mg/kg, s.c.). Naloxone produced a significant place aversion in wild-type mice, but failed to have any effect in mu-opioid receptor knock-out mice. On the other hand, both knock-out and wild-type mice treated with U50,488H spent significantly less time in the drug-paired chamber compared to their respective vehicle controls. We conclude that the mu-opioid receptor is crucial for the acquisition of naloxone-induced conditioned place aversion. Furthermore, in a separate experiment using C57BL/6 mice, the delta-selective antagonist naltrindole (10 or 30 mg/kg, s.c.) failed to produce conditioned place aversion.Taken together, these data further support the notion that naloxone produces aversion by antagonizing tonic opioid activity at the mu-opioid receptor.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11682161     DOI: 10.1016/s0306-4522(01)00333-5

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  32 in total

1.  Differential involvement of endogenous opioids in sucrose consumption and food reinforcement.

Authors:  Michael D Hayward; Alexandra Schaich-Borg; John E Pintar; Malcolm J Low
Journal:  Pharmacol Biochem Behav       Date:  2006-12-12       Impact factor: 3.533

2.  14-O-Heterocyclic-substituted naltrexone derivatives as non-peptide mu opioid receptor selective antagonists: design, synthesis, and biological studies.

Authors:  Guo Li; Lindsey C K Aschenbach; Hengjun He; Dana E Selley; Yan Zhang
Journal:  Bioorg Med Chem Lett       Date:  2008-12-29       Impact factor: 2.823

3.  MP1104, a mixed kappa-delta opioid receptor agonist has anti-cocaine properties with reduced side-effects in rats.

Authors:  Diana V Atigari; Rajendra Uprety; Gavril W Pasternak; Susruta Majumdar; Bronwyn M Kivell
Journal:  Neuropharmacology       Date:  2019-02-13       Impact factor: 5.250

4.  Activation of μ-opioid receptors in the dorsal striatum is necessary for adult social attachment in monogamous prairie voles.

Authors:  James P Burkett; Lauren L Spiegel; Kiyoshi Inoue; Anne Z Murphy; Larry J Young
Journal:  Neuropsychopharmacology       Date:  2011-07-06       Impact factor: 7.853

5.  Restricted role of CRF1 receptor for the activity of brainstem catecholaminergic neurons in the negative state of morphine withdrawal.

Authors:  Juan-Antonio Garcia-Carmona; Pilar Almela; Alberto Baroja-Mazo; M Victoria Milanes; M Luisa Laorden
Journal:  Psychopharmacology (Berl)       Date:  2011-09-21       Impact factor: 4.530

6.  Reversal effect of intra-central amygdala microinjection of L-arginine on place aversion induced by naloxone in morphine conditioned rats.

Authors:  Sara Karimi; Manizheh Karami; Hedayat Sahraei; Mahnaz Rahimpour
Journal:  Iran Biomed J       Date:  2011

7.  Enkephalin downregulation in the nucleus accumbens underlies chronic stress-induced anhedonia.

Authors:  Jean-François Poulin; Sylvie Laforest; Guy Drolet
Journal:  Stress       Date:  2013-10-31       Impact factor: 3.493

8.  Disruption of endogenous opioid activity during instrumental learning enhances habit acquisition.

Authors:  K M Wassum; I C Cely; N T Maidment; B W Balleine
Journal:  Neuroscience       Date:  2009-07-18       Impact factor: 3.590

Review 9.  Strategies for Developing κ Opioid Receptor Agonists for the Treatment of Pain with Fewer Side Effects.

Authors:  Kelly F Paton; Diana V Atigari; Sophia Kaska; Thomas Prisinzano; Bronwyn M Kivell
Journal:  J Pharmacol Exp Ther       Date:  2020-09-10       Impact factor: 4.030

10.  Motivational effects of opiates in conditioned place preference and aversion paradigm--a study in three inbred strains of mice.

Authors:  Wojciech Solecki; Anna Turek; Jakub Kubik; Ryszard Przewlocki
Journal:  Psychopharmacology (Berl)       Date:  2009-09-29       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.